Depakote ER
NDC 0074-7401, Divalproex Sodium, tablet, extended release, from AbbVie Inc..
- Product NDC
- 0074-7401
- Status
- Listed
- Labeler
- AbbVie Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021168
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIVALPROEX SODIUM250 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0074-7401-13 | 00074740113 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-7401-13) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0dc024ce-efc8-4690-7cb5-639c728fccacNADAC price for package 00074740113
GET /v1/drugs/nadac/00074740113
Use it
Look up 0074-7401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0074-7401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.